zofenopril has been researched along with avapro in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbenante, G; Fairlie, DP; Leung, D | 1 |
Agabiti-Rosei, E; Manolis, A; Omboni, S; Zava, D | 1 |
Arca, M; Berra, S; Bucci, M; CalabrĂ², P; Fulgheri, PL; Ghione, S; Modesti, PA; Omboni, S; Pirvu, O; Popescu, E; Portaluppi, F; Pozzilli, P; Taddei, S; Velican, VG; Villani, GQ; Vladoianu, M; Volpe, M | 1 |
Borghi, C; Napoli, C; Omboni, S | 1 |
Agabiti-Rosei, E; Borghi, C; Malacco, E; Manolis, A; Modesti, PA; Napoli, C; Omboni, S; Parati, G | 1 |
2 review(s) available for zofenopril and avapro
Article | Year |
---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Biphenyl Compounds; Blood Glucose; Blood Pressure; C-Reactive Protein; Captopril; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Inflammation Mediators; Irbesartan; Lipids; Male; Middle Aged; Pulse Wave Analysis; Randomized Controlled Trials as Topic; Risk Factors; Tetrazoles; Vascular Stiffness | 2017 |
3 trial(s) available for zofenopril and avapro
Article | Year |
---|---|
Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Biphenyl Compounds; Captopril; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Treatment Outcome; Young Adult | 2014 |
Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: a double-blind, randomized study.
Topics: Aged; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Systole; Tetrazoles; Treatment Outcome; Vascular Stiffness | 2016 |
Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic Synd
Topics: Aged; Biphenyl Compounds; Captopril; Female; Humans; Hydrochlorothiazide; Irbesartan; Male; Metabolic Syndrome; Middle Aged; Tetrazoles | 2016 |